CDK4/6 Inhibitors Expand the Therapeutic Options in Breast Cancer: Palbociclib, Ribociclib and Abemaciclib Tanja K. EggersmannTom DegenhardtNadia Harbeck Review Article 07 March 2019 Pages: 125 - 135
The Relationship between Exosomes and Cancer: Implications for Diagnostics and Therapeutics Wendy W. WestonTimothy GaneyH. Thomas Temple Review Article 27 February 2019 Pages: 137 - 158
First-Line Treatment of Non-Small-Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors Olivier BylickiHelene BarazzuttiChristos Chouaïd Review Article 02 March 2019 Pages: 159 - 171
A Randomized, Double-Blind Trial Comparing the Pharmacokinetics of CT-P16, a Candidate Bevacizumab Biosimilar, with its Reference Product in Healthy Adult Males Sang-Heon ChoSeunghoon HanJae-Gook Shin Original Research Article 09 March 2019 Pages: 173 - 181
Perspectives of Hospital Pharmacists Towards Biosimilar Medicines: A Survey of Polish Pharmacy Practice in General Hospitals Iga PawłowskaLeszek PawłowskiIvan Kocić Original Research Article Open access 04 March 2019 Pages: 183 - 191
Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA) Jesús HermosillaRicardo Sánchez-MartínNatalia Navas Original Research Article 14 March 2019 Pages: 193 - 205
PF-06881893 (Nivestym™), a Filgrastim Biosimilar, Versus US-Licensed Filgrastim Reference Product (US-Neupogen®): Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Safety of Single or Multiple Subcutaneous Doses in Healthy Volunteers Hsuan-Ming YaoFaith D. OtteryMartin Summers Original Research Article Open access 21 March 2019 Pages: 207 - 220
In-Use Stability of the Rituximab Biosimilar CT-P10 (Truxima®) Following Preparation for Intravenous Infusion and Storage Su Jung KimKwang Woo KimWon Yong Han Short Communication 11 February 2019 Pages: 221 - 228
LA-EP2006: A Pegfilgrastim Biosimilar Sheridan M. Hoy Adis Biosimilar Brief 18 March 2019 Pages: 229 - 232
Vestronidase Alfa: A Review in Mucopolysaccharidosis VII Emma H. McCaffertyLesley J. Scott Adis Drug Evaluation Open access 08 March 2019 Pages: 233 - 240
